These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20848514)

  • 1. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
    Schroepf S; Kappler R; Brand S; Prell C; Lohse P; Glas J; Hoster E; Helmbrecht J; Ballauff A; Berger M; von Schweinitz D; Koletzko S; Lacher M
    Inflamm Bowel Dis; 2010 Nov; 16(11):1882-90. PubMed ID: 20848514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease patients.
    Jimbo K; Ohtsuka Y; Kojima Y; Hosoi K; Ohbayashi N; Ikuse T; Aoyagi Y; Fujii T; Kudo T; Shimizu T
    Pediatr Int; 2014 Dec; 56(6):873-883. PubMed ID: 24750209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
    Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
    Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease.
    Haghbin M; Rostami-Nejad M; Forouzesh F; Sadeghi A; Rostami K; Aghamohammadi E; Asadzadeh-Aghdaei H; Masotti A; Zali MR
    Medicine (Baltimore); 2019 Jun; 98(25):e15949. PubMed ID: 31232926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.
    Bondar C; Araya RE; Guzman L; Rua EC; Chopita N; Chirdo FG
    PLoS One; 2014; 9(2):e89068. PubMed ID: 24586509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren's syndrome.
    Kim JW; Ahn MH; Jung JY; Suh CH; Han JH; Kim HA
    Clin Exp Med; 2024 Jun; 24(1):133. PubMed ID: 38900301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.
    Lacher M; Schroepf S; Helmbrecht J; Von Schweinitz D; Ballauff A; Koch I; Lohse P; Osterrieder S; Kappler R; Koletzko S
    Acta Paediatr; 2010 May; 99(5):727-733. PubMed ID: 20192940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis.
    Hosomi S; Oshitani N; Kamata N; Sogawa M; Okazaki H; Tanigawa T; Yamagami H; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Maeda K; Hirakawa K; Arakawa T
    Clin Exp Immunol; 2011 Feb; 163(2):215-24. PubMed ID: 21087446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
    Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
    BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Verhulst SJ; Ransohoff RM
    Clin Exp Immunol; 2013 Jun; 172(3):427-36. PubMed ID: 23600831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuritis: chemokine receptor CXCR3 and its ligands.
    Sørensen TL; Roed H; Sellebjerg F
    Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.